| Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
 |
World Community Grid Forums
Category: Active Research
Forum: OpenPandemics - COVID-19 Project
Thread: Covid-19 - Discuss Scientific Papers |
| No member browsing this thread |
|
Thread Status: Active Total posts in this thread: 80
|
|
| Author |
|
|
Bobzilla
Cruncher Joined: May 31, 2020 Post Count: 31 Status: Offline Project Badges: 
|
Shall we assume that if our efforts result in a cure, or at least a treatment, that said treatment and or cure, will be made free of charge to those who have made the research possible?
|
||
|
|
Jim1348
Veteran Cruncher USA Joined: Jul 13, 2009 Post Count: 1066 Status: Offline Project Badges: 
|
Shall we assume that if our efforts result in a cure, or at least a treatment, that said treatment and or cure, will be made free of charge to those who have made the research possible? Are you serious? Our contribution is a minor factor in the overall costs of making and distributing a drug. It could be important to get the process going, so that drug companies do not have to invest so much upfront in research and development, but it is just a start. And did you see any offer of free drugs on the WCG website? Let us know. |
||
|
|
Bobzilla
Cruncher Joined: May 31, 2020 Post Count: 31 Status: Offline Project Badges:
|
thats good to know, since it is a very minor thing ill move on to another research then.. bristol meyers scuibb has this covered thanks.
|
||
|
|
Jim1348
Veteran Cruncher USA Joined: Jul 13, 2009 Post Count: 1066 Status: Offline Project Badges:
|
The cures for this round are in testing now, from many companies. I consider all of these computer projects to be investments in the future. There will be new viruses that come along. Invest how you like.
|
||
|
|
robertmiles
Senior Cruncher US Joined: Apr 16, 2008 Post Count: 443 Status: Offline Project Badges:
|
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses
https://science.sciencemag.org/content/early/2020/08/26/science.abb3753 |
||
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges:
|
Acceptability of App-Based Contact Tracing for COVID-19: Cross-Country Survey Study
Epidemiological evidence shows that app-based contact tracing can suppress the spread of COVID-19 if a high enough proportion of the population uses the app and that it can still reduce the number of infections if uptake is moderate. Findings show that the willingness to install the app is very high. The available evidence suggests that app-based contact tracing may be a viable approach to control the diffusion of COVID-19. https://mhealth.jmir.org/2020/8/e19857/  |
||
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges:
|
How Influenza Vaccination Rate Variation Could Inform Pandemic-Era Vaccination Efforts
Brandon W. Yan, Frank A. Sloan, R. Adams Dudley. How Influenza Vaccination Rate Variation Could Inform Pandemic-Era Vaccination Efforts. Journal of General Internal Medicine, 2020; DOI: 10.1007/s11606-020-06129-x https://link.springer.com/article/10.1007/s11606-020-06129-x#Tab1 |
||
|
|
robertmiles
Senior Cruncher US Joined: Apr 16, 2008 Post Count: 443 Status: Offline Project Badges:
|
Antiviral used to treat cat coronavirus also works against SARS-CoV-2: U of A researchers
https://www.folio.ca/antiviral-used-to-treat-...cov-2-u-of-a-researchers/ Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication https://www.nature.com/articles/s41467-020-18096-2 DARE-19: Dapagliflozin could target key mechanisms activated in COVID-19 https://www.healio.com/news/endocrinology/202...ews&m_bt=435990753314 |
||
|
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges:
|
Audio Interview: Guidelines for COVID-19 Vaccine Deployment
Eric Rubin is the Editor-in-Chief of the New England Journal of Medicine. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. https://www.nejm.org/doi/full/10.1056/NEJMe2029435?query=NC |
||
|
|
|